Counterintuitive effect of antiviral therapy on influenza A-SARS-CoV-2 coinfection due to viral interference.
COVID-19
SARS-CoV-2
Tamiflu
coinfection
influenza virus
interferon response
interferon stimulated genes
oseltamivir
respiratory virus
viral interference
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
08 Feb 2023
08 Feb 2023
Historique:
pubmed:
18
2
2023
medline:
18
2
2023
entrez:
17
2
2023
Statut:
epublish
Résumé
The resurgence of influenza and continued circulation of SARS-CoV-2 raise the question of how these viruses interact in a co-exposed host. Here we studied virus-virus and host-virus interactions during influenza A virus (IAV) -SARS-CoV-2 coinfection using differentiated cultures of the human airway epithelium. Coexposure to IAV enhanced the tissue antiviral response during SARS-CoV-2 infection and suppressed SARS-CoV-2 replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the antiviral response and paradoxically restored SARS-CoV-2 replication. These results highlight the importance of diagnosing coinfections and compel further study of how coinfections impact the outcome of antiviral therapy.
Identifiants
pubmed: 36798412
doi: 10.1101/2023.02.07.527372
pmc: PMC9934525
pii:
doi:
Types de publication
Preprint
Langues
eng
Déclaration de conflit d'intérêts
Declaration of interests. All authors declare no conflicts of interest.